India Liver Cancer Therapeutics Market Size, Share, Trends and Forecast by Cancer Type, Therapy, Route of Administration, Distribution Channel, and Region, 2025-2033

India Liver Cancer Therapeutics Market Size, Share, Trends and Forecast by Cancer Type, Therapy, Route of Administration, Distribution Channel, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A31225

India Liver Cancer Therapeutics Market Overview:

The India liver cancer therapeutics market size reached USD 123.75 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 337.40 Million by 2033, exhibiting a growth rate (CAGR) of 10.85% during 2025-2033. The market is driven by rising liver cancer prevalence, increasing alcohol consumption, growing hepatitis infections, advancements in targeted therapies, expanding healthcare infrastructure, increasing awareness programs, and supportive government initiatives.

Report Attribute
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024 USD 123.75 Million
Market Forecast in 2033 USD 337.40 Million
Market Growth Rate (2025-2033) 10.85%


India Liver Cancer Therapeutics Market Trends:

Advancements in Targeted Therapies and Immunotherapy

The India liver cancer therapeutics market outlook is witnessing significant advancements in targeted therapies and immunotherapy, offering more effective treatment options with fewer side effects. In addition to this, the treatment success of standard chemotherapy remains limited because hepatocellular carcinoma shows resistance to therapy. Moreover, the medical community has achieved better survival rates by introducing the molecular-targeted drugs sorafenib and lenvatinib. Besides this, the popularity of immunotherapies is increasing because immune checkpoint inhibitors such as nivolumab and pembrolizumab enhance the natural defense systems' reaction to cancer cells. For example, in April 2024, India’s first indigenous CAR-T cell therapy, NexCAR19, developed by IIT Bombay, Tata Memorial Centre, and ImmunoACT, marked a significant advancement in affordable gene therapy, further strengthening the country’s position in cancer treatment innovation. Furthermore, the approval process for new therapeutic approaches along with rising clinical studies continues to develop available treatment options. Medical research centers and pharmaceutical enterprises also use their resources to develop integrated immunotherapy and targeted drug programs that enhance the treatment results. As a result, patients have access to these treatments, driven by the rising demand for precise liver cancer treatment options, which is boosting the India liver cancer therapeutics market share.

India Liver Cancer Therapeutics Market Size

Growing Adoption of Minimally Invasive and Locoregional Therapies

The India liver cancer therapeutics market is observing an increasing trend for minimally invasive (MI) and locoregional treatments because these procedures show success in treating early-stage cancers and providing palliative care. Doctors across India are widely adopting Transarterial Chemoembolization (TACE), Transarterial Radioembolization (TARE), and Radiofrequency Ablation (RFA) as targeted tumor treatments as they demonstrate minimal impact on healthy tissues. For instance, in March 2025, Terumo India launched the Occlusafe balloon occlusion catheter, enhancing precision in TACE procedures for liver cancer. This innovation aligns with India's growing adoption of MI treatments, improving outcomes and reinforcing the shift toward advanced interventional oncology solutions. The procedures benefit patients whose condition makes them ineligible for surgical resection or liver transplantation. Concurrently, the expanding number of dedicated cancer treatment facilities and enhanced imaging systems along with doctors' growing expertise in interventional oncology practices has led to wider use of these therapy methods. Additionally, locoregional treatments are gaining popularity in India’s cost-sensitive healthcare environment as they offer affordability and reduced hospitalization periods. Apart from this, the increased availability and awareness of these procedures establish them as fundamental methods in liver cancer management to enhance survival outcomes for patients, thereby driving the India liver cancer therapeutics market growth.

India Liver Cancer Therapeutics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region level for 2025-2033. Our report has categorized the market based on cancer type, therapy, route of administration and distribution channel.

Cancer Type Insights:

  • Hepatocellular Carcinoma
  • Cholangiocarcinoma
  • Hepatoblastoma
  • Angiosarcoma
  • Liver Metastasis

The report has provided a detailed breakup and analysis of the market based on the cancer type. This includes hepatocellular carcinoma, cholangiocarcinoma, hepatoblastoma, angiosarcoma, and liver metastasis.

Therapy Insights:

  • Targeted Therapy
  • Chemotherapy and Radiation Therapy
  • Immunotherapy
  • Others

A detailed breakup and analysis of the market based on the therapy have also been provided in the report. This includes targeted therapy, chemotherapy and radiation therapy, immunotherapy, and others.

Route of Administration Insights:

  • Oral
  • Intravenous
  • Others

The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes oral, intravenous, and others.

Distribution Channel Insights:

India Liver Cancer Therapeutics Market By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes hospital pharmacies, retail pharmacies, and online pharmacies.

Regional Insights:

  • North India
  • South India
  • East India
  • West India

The report has also provided a comprehensive analysis of all the major regional markets, which include North, South, East and West India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

India Liver Cancer Therapeutics Market News:

  • In December 2024, HealthCare Global Enterprises (HCG) partnered with Accenture to leverage AI, including generative AI and deep learning, for cancer research. This collaboration aims to accelerate drug discovery, enhance early liver cancer detection, and improve treatment outcomes using multi-omic patient data and advanced analytics.
  • In November 2023, Torrent Pharmaceuticals and Zydus Lifesciences entered a licensing and supply agreement to co-market Saroglitazar Magnesium for treating Non-Alcoholic SteatoHepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) in India. This partnership enhances the availability of effective treatments for liver diseases, addressing a significant unmet medical need in the country.

India Liver Cancer Therapeutics Market Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Scope of the Report

Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:

  • Cancer Type 
  • Therapy
  • Route of Administration
  • Distribution Channel
  • Region
Cancer Types Covered Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Angiosarcoma, Liver Metastasis
Therapies Covered Targeted Therapy, Chemotherapy and Radiation Therapy, Immunotherapy, Others
Route of Administrations Covered Oral, Intravenous, Others
Distribution Channels Covered Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regions Covered North India, South India, East India, West India
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the India liver cancer therapeutics market performed so far and how will it perform in the coming years?
  • What is the breakup of the India liver cancer therapeutics market on the basis of cancer type?
  • What is the breakup of the India liver cancer therapeutics market on the basis of therapy?
  • What is the breakup of the India liver cancer therapeutics market on the basis of route of administration?
  • What is the breakup of the India liver cancer therapeutics market on the basis of distribution channel?
  • What is the breakup of the India liver cancer therapeutics market on the basis of region?
  • What are the various stages in the value chain of the India liver cancer therapeutics market? 
  • What are the key driving factors and challenges in the India liver cancer therapeutics?
  • What is the structure of the India liver cancer therapeutics market and who are the key players?
  • What is the degree of competition in the India liver cancer therapeutics market? 

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India liver cancer therapeutics market from 2019-2033.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the India liver cancer therapeutics market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India liver cancer therapeutics industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
India Liver Cancer Therapeutics Market Size, Share, Trends and Forecast by Cancer Type, Therapy, Route of Administration, Distribution Channel, and Region, 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials